日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZFP148 is a transcriptional repressor of cytolytic effector CD8(+) T cell differentiation

ZFP148是细胞溶解效应CD8(+) T细胞分化的转录抑制因子

Xiao, Tong; Chen, Xingyu; Song, No-Joon; Brown, Ryan J; Ma, Anjun; Mandula, Jay K; Yousif, Amir; Wang, Yi; Le, Minh Quynh May; Li, Jianying; Gao, Fengxia; Weaver, Bella; Chen, Heng-Yi; Lay, Fang-Yun; Sundi, Debasish; Velegraki, Maria; Weltge, Payton; Merchant, Juanita L; Rubinstein, Mark P; Oestreich, Kenneth J; Lio, Chan-Wang Jerry; Ghoneim, Hazem E; Li, Xue; Theodorescu, Dan; Xin, Gang; Ma, Qin; Cui, Weiguo; Li, Zihai

Concurrent loss of the Y chromosome in cancer and T cells impacts outcome

癌症和T细胞中Y染色体的同时丢失会影响预后。

Xingyu Chen ,Yiling Shen # ,Suhyeon Choi #,Hany A Abdel-Hafiz,Mukta Basu,Lena Hoelzen,Martina Tufano,Saravana Kumar Kailasam Mani,Maryam Ranjpour,Jiani Zhu,V Krishnan Ramanujan,Ekaterina K Koltsova,Vinicius F Calsavara,Simon R V Knott,Dan Theodorescu

Concurrent loss of the Y chromosome in cancer and T cells impacts outcome

癌症和T细胞中Y染色体的同时丢失会影响预后。

Xingyu Chen ,Yiling Shen # ,Suhyeon Choi # ,Hany A Abdel-Hafiz ,Mukta Basu ,Lena Hoelzen ,Martina Tufano ,Saravana Kumar Kailasam Mani ,Maryam Ranjpour ,Jiani Zhu ,V Krishnan Ramanujan ,Ekaterina K Koltsova ,Vinicius F Calsavara ,Simon R V Knott ,Dan Theodorescu

Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning

利用可解释的多模态深度学习预测肌层浸润性膀胱癌对新辅助化疗的反应

Bai, Zilong; Osman, Mohamed; Brendel, Matthew; Tangen, Catherine M; Flaig, Thomas W; Thompson, Ian M; Plets, Melissa; Scott Lucia, M; Theodorescu, Dan; Gustafson, Daniel; Daneshmand, Siamak; Meeks, Joshua J; Choi, Woonyoung; Dinney, Colin P N; Elemento, Olivier; Lerner, Seth P; McConkey, David J; Faltas, Bishoy M; Wang, Fei

Genes driving three-dimensional growth of immortalized cells and cancer

驱动永生化细胞和癌症三维生长的基因

Mukta Basu # ,Jin-Fen Xiao # ,Saravana Kumar Kailasam Mani ,Fangyuan Qu ,Yongqi Lin ,Jason Duex ,Huihui Ye ,Vanessa Neang ,Dan Theodorescu

Sex differences in bladder cancer: understanding biological and clinical implications

膀胱癌的性别差异:理解其生物学和临床意义

Chaudhary, Prakash; Singha, Biplab; Abdel-Hafiz, Hany A; Velegraki, Maria; Sundi, Debasish; Satturwar, Swati; Parwani, Anil V; Grivennikov, Sergei I; You, Sungyong; Goodridge, Helen S; Ma, Qin; Chang, Yuzhou; Ma, Anjun; Zheng, Bin; Theodorescu, Dan; Li, Zihai; Li, Xue

Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer

《膀胱癌》期刊成为IBCN官方合作伙伴;加强全球膀胱癌领域的合作

Dyrskjøt, Lars; Black, Peter; Lerner, Seth; Theodorescu, Dan

Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?

黑人晚期前列腺癌患者在系统性治疗方面面临的差异:我们目前处于什么阶段?

Gong, Jun; Kim, Daniel M; De Hoedt, Amanda M; Bhowmick, Neil; Figlin, Robert; Kim, Hyung L; Sandler, Howard; Theodorescu, Dan; Posadas, Edwin; Freedland, Stephen J

Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapy

调节容量调节阴离子通道可改变对铂类化疗的敏感性

Lily Elizabeth R Feldman ,Saswat Mohapatra ,Robert T Jones ,Mathijs Scholtes ,Charlene B Tilton ,Michael V Orman ,Molishree Joshi ,Cailin S Deiter ,Travis P Broneske ,Fangyuan Qu ,Corazon Gutierrez ,Huihui Ye ,Eric T Clambey ,Sarah Parker ,Tokameh Mahmoudi ,Tahlita Zuiverloon ,James C Costello ,Dan Theodorescu

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

在COXEN联合新辅助化疗治疗肌层浸润性膀胱癌的II期研究中,分子亚型与病理反应、无进展生存期(PFS)和总生存期(OS)的相关性

Lerner, Seth P; McConkey, David J; Tangen, Catherine M; Meeks, Joshua J; Flaig, Thomas W; Hua, Xing; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M Scott; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Choi, Woonyoung; Bangs, Rick; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M Jr